Tempus AI Stock Soars to All-Time High

Tempus AI (TEM) shares soared to an all-time high Thursday, extending their recent rally as the tech firm announced a collaboration with the nonprofit Institute for Follicular Lymphoma Innovation (IFLI) to develop targeted therapies for the disease.

Tempus said its data analytics platform Lens will be used in the collaboration to help researchers “derive AI-driven insights to accelerate the development of FL treatments in an effort to improve patient outcomes.”

“We are excited to…